Ontology highlight
ABSTRACT:
SUBMITTER: Lin X
PROVIDER: S-EPMC6691560 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
Lin Xiaojing X Yosaatmadja Yuliana Y Kalyukina Maria M Middleditch Martin J MJ Zhang Zhen Z Lu Xiaoyun X Ding Ke K Patterson Adam V AV Smaill Jeff B JB Squire Christopher J CJ
ACS medicinal chemistry letters 20190703 8
Aberration in FGFR4 signaling drives carcinogenesis and progression in a subset of hepatocellular carcinoma (HCC) patients, thereby making FGFR4 an attractive molecular target for this disease. Selective FGFR4 inhibition can be achieved through covalently targeting a poorly conserved cysteine residue in the FGFR4 kinase domain. We report mass spectrometry assays and cocrystal structures of FGFR4 in covalent complex with the clinical candidate BLU554 and with a series of four structurally related ...[more]